↓ Skip to main content

Cochrane Database of Systematic Reviews

Antipsychotic medication for childhood-onset schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, July 2007
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

policy
1 policy source
twitter
8 tweeters

Citations

dimensions_citation
31 Dimensions

Readers on

mendeley
154 Mendeley
Title
Antipsychotic medication for childhood-onset schizophrenia
Published in
Cochrane database of systematic reviews, July 2007
DOI 10.1002/14651858.cd004027.pub2
Pubmed ID
Authors

Eilis Kennedy, Ajit Kumar, Soumitra S Datta

Abstract

Childhood-onset schizophrenia is schizophrenia with onset prior to the age of 13 years. Although it is rare, people who suffer from schizophrenia at an early age appear to have a clinically severe form of the illness with poor long-term prognosis. Antipsychotic medication is one way of managing this rare but serious mental illness.

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 154 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 <1%
United States 1 <1%
Unknown 152 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 27 18%
Student > Master 22 14%
Researcher 19 12%
Student > Ph. D. Student 17 11%
Student > Doctoral Student 14 9%
Other 25 16%
Unknown 30 19%
Readers by discipline Count As %
Medicine and Dentistry 54 35%
Psychology 23 15%
Nursing and Health Professions 10 6%
Social Sciences 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 19 12%
Unknown 37 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 April 2016.
All research outputs
#3,284,736
of 17,361,274 outputs
Outputs from Cochrane database of systematic reviews
#5,895
of 11,660 outputs
Outputs of similar age
#24,077
of 132,858 outputs
Outputs of similar age from Cochrane database of systematic reviews
#40
of 102 outputs
Altmetric has tracked 17,361,274 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,660 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.0. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 132,858 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.